PE / VC
2022
$44 000 M
Chicago, Illinois, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Apogem Capital is a leading alternatives investment manager with decades of experience investing in the middle market.
Apogem Capital was created by combining three leading middle market investment firms—GoldPoint Partners, Madison Capital Funding, and PA Capital—into a single unified investment firm. Together, we offer comprehensive investment capabilities in private equity, private credit, and real assets.
Apogem Capital manages $42 billion in AUM* and is a wholly owned subsidiary of New York Life Insurance Company, one of the world’s largest life insurers.
Industry
Region of investment
Apogem Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Apogem Secondary Fund VII
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Energy
CleanTech
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$776 M
|
February 2025
|
|
PA Secondary Fund VI
|
Private Equity (PE)
|
Healthcare Services
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$614 M
|
June 2022
|
|
PA Small Company Private Equity Fund IX
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Healthcare Services
SaaS
Software
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$673 M
|
March 2015
|
|
PA Secondary Fund V
|
Private Equity (PE)
|
Healthcare Services
Industrial
SaaS
Security
Software
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$14 M
|
March 2016
|
|
Apogem Private Equity Fund XI Cayman
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$75 M
|
May 2026
|